Balaji Amines Limited has fixed Friday, July 3, 2026, as the record date to determine shareholder eligibility for the final dividend for the financial year ended March 31, 2026. The Board of Directors had previously recommended a dividend of ₹11 per equity share, representing 550% of the face value of ₹2 each, at its meeting held on May 13, 2026. This payout is subject to the approval of shareholders at the Annual General Meeting (AGM) scheduled for Friday, July 10, 2026. If approved, the dividend will be paid within 30 days from the conclusion of the AGM, subject to deduction of tax at source.

The record date has been fixed in compliance with Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The dividend will be paid to all Beneficial Owners in respect of shares held in dematerialized form as per the data available from the National Securities Depository Limited and the Central Depository Services (India) Limited as of the close of business hours on July 3, 2026. Members holding shares in physical form will receive the dividend after giving effect to valid transmission or transposition requests lodged with the company as of the close of business hours on the same date.

AGM Details

The 38th Annual General Meeting of the company will be held on Friday, July 10, 2026. The meeting will transact ordinary business, including the adoption of audited financial statements and the declaration of the recommended dividend. The company has informed the BSE Limited and the National Stock Exchange of India Limited regarding the record date and AGM schedule.

Balaji Amines Co-Chairman Anup Pratap Reddy has outlined a positive growth outlook for the company, projecting volume growth of 10-15% for FY27 alongside an EBITDA margin in the range of 22-23%. The guidance reflects the company's confidence in its operational trajectory as key production capacities are scaled up across multiple product segments.

Growth Outlook and Margin Guidance

The following table summarizes the key projections shared by Co-Chairman Anup Pratap Reddy:

Medium-Term Expansion Driven by Key Product Lines

Beyond FY27, Balaji Amines is targeting a more accelerated volume growth of 20-30% over the medium term. This higher growth trajectory is expected to be supported by increased production across four key product lines:

• DME (Dimethyl Ether)
• NMM (N-Methyl Morpholine)
• ACN (Acetonitrile)
• BSCL (Bis(2-chloroethyl) amine or related specialty chemical, as referenced in source)

The ramp-up in production capacity across these segments is central to the company's medium-term volume growth strategy, as highlighted by the Co-Chairman.

Summary

Balaji Amines has articulated a clear near-term and medium-term growth roadmap. For FY27, the company targets volume growth of 10-15% with EBITDA margins of 22-23%, while its medium-term ambition of 20-30% volume growth is anchored in expanding production of DME, NMM, ACN, and BSCL.